Harvard Bioscience (HBIO) News Today $0.61 +0.01 (+1.65%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$0.60 -0.01 (-1.64%) As of 03/28/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Russian scientist working at Harvard Medical School detained by ICE — because she didn’t properly declare frog embryosMarch 30 at 5:06 AM | msn.comRussian medical researcher at Harvard, who protested the Ukraine war, detained by ICEMarch 28 at 9:18 PM | msn.comRussian researcher at Harvard being held after failing to declare frog embryos at customsMarch 28 at 9:18 PM | abcnews.go.comA Harvard scientist from Russia has been detained by ICE since February for failing to declare frog embryosMarch 28 at 9:18 PM | msn.comRussian scientist at Harvard Medical School detained by ICE at Boston airportMarch 28 at 6:45 AM | msn.comBenchmark Lowers Harvard Bioscience (NASDAQ:HBIO) Price Target to $4.50March 26, 2025 | americanbankingnews.comAnalysts Offer Insights on Healthcare Companies: Harvard Bioscience (HBIO) and Enlivex (ENLV)March 26, 2025 | markets.businessinsider.comHarvard Bioscience price target lowered to $4.50 from $5.50 at BenchmarkMarch 26, 2025 | markets.businessinsider.comHarvard Law Students Vote for Endowment to Sever Israel TiesMarch 15, 2025 | msn.comParineeti Chopra calls herself ‘Harvard wife’, cheers for husband Raghav Chadha as he completes leadership programMarch 15, 2025 | msn.comHarvard Bioscience, Inc. (NASDAQ:HBIO) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comHarvard Bioscience Inc (HBIO) Q4 2024 Earnings Call Highlights: Navigating Challenges with ...March 13, 2025 | gurufocus.comQ4 2024 Harvard Bioscience Inc Earnings Call TranscriptMarch 13, 2025 | gurufocus.comHarvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025March 12, 2025 | markets.businessinsider.comHarvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025March 12, 2025 | globenewswire.comHarvard Bioscience Shares Decline on Going-Concern WarningMarch 12, 2025 | marketwatch.comHarvard Bioscience sees Q1 revenue $19M-$21MMarch 12, 2025 | markets.businessinsider.comHarvard Bioscience, Inc. (HBIO) Q4 2024 Earnings Call TranscriptMarch 12, 2025 | seekingalpha.comHarvard Bioscience: Exploring Alternative Sources of Capital That Would Allow Refinancing of Debt by June 30 >HBIOMarch 12, 2025 | marketwatch.comHarvard Bioscience reports Q4 adjusted EPS 6c vs. 4c last yearMarch 12, 2025 | markets.businessinsider.comHarvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial ResultsMarch 12, 2025 | investing.comHarvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial ResultsMarch 12, 2025 | globenewswire.comHarvard Announces a Hiring Freeze as Funding Is ThreatenedMarch 12, 2025 | nytimes.comHarvard, MIT, others announce hiring freezes amid Trump funding cuts. What it means.March 12, 2025 | msn.comHarvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology MeetingFebruary 24, 2025 | globenewswire.comHarvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ETFebruary 24, 2025 | globenewswire.comHarvard experts say one food is 'go-to' for better gut healthFebruary 21, 2025 | msn.comHarvard Bioscience stock hits 52-week low at $1.23February 19, 2025 | investing.comStanford, Harvard Warn of ‘Deep Impacts’ From Trump CutsFebruary 11, 2025 | bloomberg.comHarvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 22.8% in JanuaryHarvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 654,400 shares, an increase of 22.8% from the December 31st total of 533,100 shares. Based on an average trading volume of 166,000 shares, the short-interest ratio is currently 3.9 days.January 31, 2025 | marketbeat.comHBIO Stock Touches 52-Week Low at $1.79 Amid Market ChallengesJanuary 24, 2025 | msn.comOne Harvard Bioscience Insider Raised Their Stake In The Previous YearJanuary 19, 2025 | finance.yahoo.comHarvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200 Day Moving Average - Here's WhyHarvard Bioscience (NASDAQ:HBIO) Stock Passes Below 200-Day Moving Average - Here's WhyJanuary 16, 2025 | marketbeat.comHarvard Bioscience, Inc. to Participate in the Sidoti Micro Cap ConferenceJanuary 13, 2025 | finance.yahoo.comHarvard Bioscience, Inc. to Participate in the Sidoti Micro Cap ConferenceJanuary 13, 2025 | globenewswire.comHarvard Bioscience (NASDAQ:HBIO) Shares Pass Below Two Hundred Day Moving Average - Here's WhyHarvard Bioscience (NASDAQ:HBIO) Share Price Passes Below 200-Day Moving Average - Should You Sell?December 13, 2024 | marketbeat.comHarvard opens access to 1 million books for training AI modelsDecember 13, 2024 | msn.comHarvard Bioscience files $100M mixed securities shelfDecember 6, 2024 | tipranks.com272 Capital LP Sells 943,108 Shares of Harvard Bioscience, Inc. (NASDAQ:HBIO)272 Capital LP reduced its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO - Free Report) by 61.4% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 592,712 shares of the medical instruments supplier's stock after selDecember 1, 2024 | marketbeat.comHarvard Bioscience, Inc. (NASDAQ:HBIO) Short Interest Up 13.8% in OctoberHarvard Bioscience, Inc. (NASDAQ:HBIO - Get Free Report) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 398,900 shares, a growth of 13.8% from the October 15th total of 350,600 shares. Based on an average daily volume of 116,700 shares, the short-interest ratio is currently 3.4 days.November 18, 2024 | marketbeat.comHarvard Bioscience, Inc. (NASDAQ:HBIO) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | msn.comHarvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comHarvard Bioscience Reveals Q3 2024 Financial ResultsNovember 8, 2024 | markets.businessinsider.comHarvard Bioscience Announces Third Quarter 2024 Financial ResultsNovember 7, 2024 | markets.businessinsider.comHarvard Bioscience (NASDAQ:HBIO) Stock, Option ChainNovember 6, 2024 | benzinga.comHarvard Bioscience Inc (HBIO) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comHoward, the 'Black Harvard' where Harris will spend election nightNovember 3, 2024 | msn.comZacks Industry Outlook Highlights Mettler-Toledo International and Harvard BioscienceNovember 1, 2024 | finance.yahoo.comHarvard Bioscience (HBIO) Set to Announce Earnings on ThursdayHarvard Bioscience (NASDAQ:HBIO) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=617720)October 31, 2024 | marketbeat.comHarvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ETOctober 29, 2024 | globenewswire.com Remove Ads Get Harvard Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address HBIO Media Mentions By Week HBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HBIO News Sentiment▼-0.400.80▲Average Computer and Technology News Sentiment HBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HBIO Articles This Week▼105▲HBIO Articles Average Week Remove Ads Get Harvard Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TMO News Today A News Today MTD News Today WAT News Today ILMN News Today TECH News Today CRL News Today BIO News Today BRKR News Today PACB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HBIO) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harvard Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
